Although this contradicts recent evidence that suggests periostin primarily interacts with ovarian cancer cells via an αvß3 integrin-dependent mechanism [24], it also suggests a delicate balance may exist between different integrin receptors on the cell surface that dictate specificity to the ECM. The gene discussed is POSTN; the disease is ovarian carcinoma.